COM:CINGULATE
Cingulate Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
cingulate.comcrunchbase
cingulate-therapeuticslinkedin
cingulateincipo date
Dec 08, 2021
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It...Show More